Excerpt from August 30, 2010 press release . . . BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has
NEWS
Hi All, The AMDA has been working with Pfizer on supporting some proposed legislation in California that is intended to
NEWS
Genzyme would like to provide an update to the US Pompe community regarding the transition to commercial LumizymeTM (alglucosidase alfa)
NEWS
The AMDA is excited to announce a research grant opportunity for applicants who are involved in Pompe Disease research. This
NEWS
The AMDA is excited to announce a research grant opportunity for applicants who are involved in Pompe Disease research. This
NEWS